Innovative Veterinary Solutions for Antimicrobial Resistance: Capacity Building

IDRC and the UK’s Global AMR Innovation Fund are partnering on a new initiative aimed at reducing the emerging risk that antimicrobial resistance in animals poses to global health and food security. This initiative will fund research to develop new animal vaccines and other innovations to reduce the misuse of antibiotics in livestock and aquaculture production, particularly in low and middle-income countries.

The ultimate intended outcome of the research program will be to reduce antimicrobial resistance and the threat it poses to human and animal health through the prudent and reduced use of antimicrobials. The research will analyze and address the local contexts and realities that drive antimicrobial use patterns on farms in the Global South in order to ensure that innovations are relevant, feasible, practical, and appropriate for uptake and use by smallholder farmers.

This project will support the InnoVet-AMR program by covering operational costs. Separate project approval documents will authorize the execution of individual research projects and activities related to program governance, communication, and evaluation, as well as research projects supported by the program.

InnoVet-AMR is a four-year, CA$27.9 million partnership between IDRC and the UK government’s Global AMR Innovation Fund, which is part of the Department of Health and Social Care. The initiative responds to a need identified by the international scientific and development communities to reduce the emerging risk that antimicrobial resistance in animals poses to global health and food security.

Project ID

108919

Project status

Active

Duration

47 months

IDRC Officer

Santiago Alba Corral

Total funding

CA$ 436,384

Program

InnoVet-AMR: Innovative Veterinary Solutions for Antimicrobial Resistance